CEREBROLYSIN – is a neuropeptide that provides neuroprotective and neurotrophic effects. It was developed to treat Alzheimer’s disease, vascular dementia, stroke, head traumas and other neurodegenerative diseases. Cerebrolysin consists of peptides obtained from the brain of young animals and is able to cross the blood-brain barrier. As an anti-Alzheimer’s drug it works by decreasing the production of beta amyloid protein in the brain, which is responsible for the progression and onset of Alzheimer’s disease. Besides, Cerebrolysin acts as a nootropic agent – prevents neuron cells death, restore their functions and stimulates their growth (neurogenesis), thus improving cognition, restoring and enhancing memory and learning. Cerebrolysin is able to maintain the level of the neurotransmitters such as serotonin, choline and noradrenalin. Read more about Cerebrolysin.
INDICATION FOR USE
- Alzheimer’s Disease
- Chronic Cerebrovascular Pathology (Encephalopathy)
- Ischemic Stroke (Acute Phase and Recovery)
- Traumatic Brain Injury (Concussion, Post-Surgery on the Brain)
- Mental Retardation and Attention Deficit in Children
- Dementia Syndromes of Different Genesis
- Endogenous Depression Resistant to Antidepressants
INSTRUCTION FOR USE
Active substance: cerebrolysin concentrate (complex of peptides obtained from the porcine brain) 215,2mg.
Excipients: sodium hydroxide, water for injections.
Cerebrolysin injections: for intramuscular injection (5ml) or intravenous drip infusion (10ml) only. The dose and duration depends on the nature and severity of the disease, as well as the patientТs age. It is possible to administer a single dose of 50 ml , but more preferably, a course of treatment – daily injection for 10-20 days.
Acute conditions (ischemic stroke, traumatic brain injury, brain surgery complications): recommended dose is 10ml-50ml.
In the residual period of stroke and traumatic brain and spinal cord: recommended dose is 5ml-50ml.
Psychoorganic syndrome and depression: recommended dose is 5ml-30ml.
Alzheimer’s disease, vascular dementia and Alzheimer-combined vascular genesis: recommended dose is 5ml-30ml.
In neuro pediatric practice: recommended dose is 0.1-0.2 ml/kg body weight.
PRODUCER: Ebewe Pharma .
NOTE: Please consult your physician prior to using this or any other nutritional supplements or medications.
Please, contact us if you have any questions.